CNBX Pharmaceuticals Inc. (CNBX)

USD 0.01

(5.93%)

Revenue Summary of CNBX Pharmaceuticals Inc.

  • CNBX Pharmaceuticals Inc.'s latest annual revenue in 2023 was 410.16 Thousand USD , up 1269.13% from previous year.
  • CNBX Pharmaceuticals Inc.'s latest quarterly revenue in 2024 Q1 was 89.43 Thousand USD , down -10.56% from previous quarter.
  • CNBX Pharmaceuticals Inc. reported a annual revenue of 29.95 Thousand USD in annual revenue 2022, down 0.0% from previous year.
  • CNBX Pharmaceuticals Inc. reported a annual revenue of - USD in annual revenue 2021, down -100.0% from previous year.
  • CNBX Pharmaceuticals Inc. reported a quarterly revenue of 89.43 Thousand USD for 2024 Q1, down -10.56% from previous quarter.
  • CNBX Pharmaceuticals Inc. reported a quarterly revenue of 310.16 Thousand USD for 2024 Q3, down -56.76% from previous quarter.

Annual Revenue Chart of CNBX Pharmaceuticals Inc. (2023 - 2005)

Historical Annual Revenue of CNBX Pharmaceuticals Inc. (2023 - 2005)

Year Revenue Revenue Growth
2023 410.16 Thousand USD 1269.13%
2022 29.95 Thousand USD 0.0%
2021 - USD -100.0%
2020 7157.00 USD -27.29%
2019 9843.00 USD 2.52%
2018 9601.00 USD 68.91%
2017 5684.00 USD -94.95%
2016 112.5 Thousand USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%

Peer Revenue Comparison of CNBX Pharmaceuticals Inc.

Name Revenue Revenue Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -441.658%
Evofem Biosciences, Inc. 18.21 Million USD 97.749%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.666%
Qrons Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 78.77%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 97.4%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -2227.706%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 98.09%
Intellipharmaceutics International Inc. 65.72 Thousand USD -524.034%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 93.05%
Marizyme, Inc. 645.81 Thousand USD 36.488%
Genus plc 668.8 Million USD 99.939%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.833%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -314.333%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -434.34%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -937.919%
MultiCell Technologies, Inc. 49.32 USD -831540.308%
ONE Bio Corp. 52.29 Million USD 99.216%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.175%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -738.783%
Q BioMed Inc. 284.35 Thousand USD -44.246%
Emmaus Life Sciences, Inc. 29.59 Million USD 98.614%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.717%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 26.456%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD -485.95%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 37.712%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.997%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -40957.558%
Enzolytics Inc. 52.79 Thousand USD -676.887%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 32.597%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.967%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -192.469%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 33.564%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.951%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 58.89%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.152%
BioStem Technologies, Inc. 16.68 Million USD 97.542%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -73.387%
Regen BioPharma, Inc. 236.56 Thousand USD -73.387%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 70.039%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 13.418%
SYBLEU INC 11.69 Thousand USD -3406.883%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 94.734%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -3055.115%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -937.499%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 87.683%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 93.846%
IntelGenx Technologies Corp. 1.03 Million USD 60.523%
Gelesis Holdings, Inc. 25.76 Million USD 98.408%
CSL Limited 14.8 Billion USD 99.997%
Cellectis S.A. 755 Thousand USD 45.674%